Skip to main content
Equibles

FMR LLC

Position in RNA — Atrium Therapeutics, Inc.

CIK 315066 BOSTON, MA
Back to RNA Full portfolio

Position in RNA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$451,004
+$59,371 QoQ
Shares Held
33,532
+14.5% QoQ
Ownership
0.196%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 154 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in RNA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,908,415,112 across 370 Biotechnology names. RNA ranks #228 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 5,231,452 $4,853,584,218
2 ALNY
Alnylam Pharmaceuticals, Inc.
 15,023,962 $4,522,663,276
3 MRNA
Moderna, Inc.
 51,859,891 $3,631,748,165
4 ROIV
Roivant Sciences Ltd.
 81,020,390 $2,867,311,601
5 RVMD
Revolution Medicines, Inc.
 12,200,422 $2,284,895,029
6 IONS
Ionis Pharmaceuticals Inc
 24,631,956 $1,953,067,789
7 INSM
INSMED Inc
 16,143,583 $1,721,228,815
8 KRYS
Krystal Biotech, Inc.
 4,418,197 $1,642,111,277

All Filings in RNA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $451,004 33,532
2026-03-31 $391,633 29,292